ConductScience.org, home

Paper6542011

Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare.

Reddel RR and 1 other. Eur J Cancer Clin Oncol, 1984. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Papers, record 6542011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6542011

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare.
PubMed
Journal
Eur J Cancer Clin Oncol
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.4
iCite
Revised in PubMed
2019-09-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reddel RRR R
2Sutherland RLR L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
TamoxifenMajor topic
Cell Count
Cell Division
Cells, Cultured
Dose-Response Relationship, Drug
Estradiol
Female
Flow Cytometry
Humans
Interphase
Stimulation, Chemical
Time Factors

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
37324231Metabolic flare phenomenon mimicking disease progression on 18Flouride- Fluorodeoxyglucose PET/CT scan in breast cancer treated with paclitaxel-based chemotherapy.Asia Ocean J Nucl Med Biol2023https://conductscience.org/library/papers/37324231PubMed
36992561Mitocans induce lipid flip-flop and permeabilize the membrane to signal apoptosis.Biophys J2023https://conductscience.org/library/papers/36992561PubMed
33117280Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33117280PubMed
32718075PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.Cancers (Basel)2020https://conductscience.org/library/papers/32718075PubMed
32229068
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.
Nucl Med Biol2021https://conductscience.org/library/papers/32229068PubMed
24345432
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Breast Cancer Res2013https://conductscience.org/library/papers/24345432PubMed
23134774A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.BMC Syst Biol2012https://conductscience.org/library/papers/23134774PubMed
22419778Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.Endocr Rev2012https://conductscience.org/library/papers/22419778PubMed
20386540EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy.Br J Cancer2010https://conductscience.org/library/papers/20386540PubMed
18716795Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.J Cancer Res Clin Oncol2009https://conductscience.org/library/papers/18716795PubMed
15750629Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.Oncogene2005https://conductscience.org/library/papers/15750629PubMed
10619490Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.Cell Prolif1999https://conductscience.org/library/papers/10619490PubMed
8054267Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.Br J Cancer1994https://conductscience.org/library/papers/8054267PubMed
8012034Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells.Breast Cancer Res Treat1994https://conductscience.org/library/papers/8012034PubMed
3606944Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.Br J Cancer1987https://conductscience.org/library/papers/3606944PubMed
2661195Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs1989https://conductscience.org/library/papers/2661195PubMed
2605344Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.Breast Cancer Res Treat1989https://conductscience.org/library/papers/2605344PubMed
1429832Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.J Cancer Res Clin Oncol1992https://conductscience.org/library/papers/1429832PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6542011

GET https://conductscience.org/api/papers/v1/6542011/authors